{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:47:56Z","timestamp":1784630876095,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejphar.2013.03.039","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T02:02:43Z","timestamp":1364954563000},"page":"52-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Characterization of a novel high-potency positive modulator of Kv7 channels"],"prefix":"10.1016","volume":"709","author":[{"given":"William","family":"Dalby-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hougaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin S.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle K.","family":"Erichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Grunnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K.","family":"Ahring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle","family":"Christophersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Str\u00f8b\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.03.039_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2013.03.039_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuropharm.2006.07.001","article-title":"The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels","volume":"51","author":"Bentzen","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.03.039_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.09.005","article-title":"Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX)","volume":"83","author":"Bialer","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2013.03.039_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.03.039_bib5","doi-asserted-by":"crossref","first-page":"0008251","DOI":"10.1371\/journal.pone.0008251","article-title":"The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes","volume":"4","author":"Blom","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2013.03.039_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1528-1167.2012.03441.x","article-title":"The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (Kv7) potassium channels","volume":"53","author":"Brickel","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.03.039_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/283673a0","article-title":"Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone","volume":"283","author":"Brown","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.03.039_bib8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","article-title":"Neural KCNQ (Kv7) channels","volume":"156","author":"Brown","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/jm800689g","article-title":"Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior","volume":"52","author":"Butini","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2013.03.039_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0198-53","article-title":"A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family","volume":"18","author":"Charlier","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2013.03.039_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1077771","article-title":"KCNQ1 gain-of-function mutation in familial atrial fibrillation","volume":"299","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.03.039_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2007.09.023","article-title":"Effect of the new antiepileptic drug retigabine in a rodent model of mania","volume":"12","author":"Dencker","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2013.03.039_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2009.09.040","article-title":"Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder","volume":"207","author":"Dencker","year":"2010","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.ejphar.2013.03.039_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(02)01287-6","article-title":"Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352","volume":"437","author":"Dupuis","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib15","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2165\/11594640-000000000-00000","article-title":"Novel medications for epilepsy","volume":"71","author":"Fattore","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2013.03.039_bib16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1476-5381.2009.00131.x","article-title":"New tricks for old dogs: KCNQ expression and role in smooth muscle","volume":"156","author":"Greenwood","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1113\/jphysiol.2005.086835","article-title":"Kv7\/KCNQ\/M and HCN\/h, but not KCa2\/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells","volume":"566","author":"Gu","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2007.05.029","article-title":"The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine","volume":"570","author":"Hansen","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib19","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.106.106757","article-title":"The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat","volume":"318","author":"Hansen","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.039_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bjp.0707281","article-title":"Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels","volume":"151","author":"Hougaard","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib21","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1529\/biophysj.106.101287","article-title":"Inactivation as a new regulatory mechanism for neuronal Kv7 channels","volume":"92","author":"Jensen","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2013.03.039_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35036198","article-title":"Neuronal KCNQ potassium channels: physiology and role in disease","volume":"1","author":"Jentsch","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.039_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1152\/physiol.00031.2005","article-title":"The KCNQ1 potassium channel: from gene to physiological function","volume":"20","author":"Jespersen","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ejphar.2013.03.039_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.105.083923","article-title":"Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels","volume":"314","author":"Korsgaard","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.039_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/jn.00574.2005","article-title":"Characterization of M-current in ventral tegmental area dopamine neurons","volume":"96","author":"Koyama","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yhbeh.2004.03.002","article-title":"Primer effects by conspecific odors in house mice: a new perspective in the study of primer effects on reproductive activities","volume":"46","author":"Koyama","year":"2004","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ejphar.2013.03.039_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)80556-5","article-title":"KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness","volume":"96","author":"Kubisch","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2013.03.039_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1528-1167.2011.03364.x","article-title":"The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use","volume":"53","author":"Large","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.03.039_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2013.03.039_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/chemse\/24.3.289","article-title":"Induction of estrus in grouped female mice (Mus domesticus) by synthetic analogues of preputial gland constituents","volume":"24","author":"Ma","year":"1999","journal-title":"Chem. Senses"},{"key":"10.1016\/j.ejphar.2013.03.039_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/mol.58.2.253","article-title":"Modulation of KCNQ2\/3 potassium channels by the novel anticonvulsant retigabine","volume":"58","author":"Main","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2007.07.002","article-title":"Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety","volume":"53","author":"Munro","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.03.039_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/mol.61.4.921","article-title":"Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission","volume":"61","author":"Otto","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbr.2008.12.027","article-title":"Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania","volume":"198","author":"Redrobe","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.039_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.108.137794","article-title":"In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2\/Q3 (Kv7.2\/Kv7.3) activator in rodent anticonvulsant models","volume":"326","author":"Roeloffs","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.039_bib36","first-page":"1063","article-title":"Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels","volume":"50","author":"Rundfeldt","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2013.03.039_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(00)00866-1","article-title":"The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2\/3 subunits","volume":"282","author":"Rundfeldt","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2013.03.039_bib39","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0028-3908(01)00029-6","article-title":"KCNQ4 channel activation by BMS-204352 and retigabine","volume":"40","author":"Schr\u00f8der","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.03.039_bib40","doi-asserted-by":"crossref","first-page":"C859","DOI":"10.1152\/ajpcell.2001.280.4.C859","article-title":"KCNQ4 channels expressed in mammalian cells: functional characteristics and pharmacology","volume":"280","author":"S\u00f8gaard","year":"2001","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1124\/jpet.108.146944","article-title":"Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission","volume":"328","author":"Sotty","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.039_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0896-6273(02)00790-0","article-title":"Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis","volume":"35","author":"Suh","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2013.03.039_bib43","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine","volume":"21","author":"Tatulian","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.039_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(96)00073-8","article-title":"D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures","volume":"303","author":"Tober","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(03)01426-2","article-title":"Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex","volume":"464","author":"van Rijn","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib46","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.03.039_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1087057104268749","article-title":"A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells","volume":"9","author":"Weaver","year":"2004","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ejphar.2013.03.039_bib48","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/mol.107.043216","article-title":"N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2\/Q3 potassium channel activator","volume":"73","author":"Wickenden","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.039_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/mol.58.3.591","article-title":"Retigabine, a novel anti-convulsant, enhances activation of KCNQ2\/Q3 potassium channels","volume":"58","author":"Wickenden","year":"2000","journal-title":"Mol. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913002574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913002574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:51:07Z","timestamp":1562867467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913002574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0014299913002574"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.039","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a novel high-potency positive modulator of Kv7 channels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}